Petersen DD, Swartout J. Cincinnati OH : U. Environmental Protection Agency; Jul. Go to this page to see a list of supported browsers or return to the regular view. Prev Page 0 of 0. Cincinnati, OH. Effects of oral pentaerythritol tetranitrate in cardiac failure and angina pectoris. Assessment by hemodynamic measurement and exercise capacity.
Atlanta, GA: U. Minimal risk levels MRLs. June Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol. Br Med J 1: β Bronchopulmonary effects of pentaerythrityl tetranitrate and isoproterenol. J Pharmacol Exp Ther β Induction of microRNA by nitric oxide in endothelial cells is required for nitrovasodilator resistance via targeting of prostaglandin I2 synthase. Circulation β Pentaerythritol tetranitrate sustained-release tablets: Relation of in vitro release of the drug to blood pressure changes after administration of anesthetized cats.
J Pharm Sci β Non-intermittent long-term administration of pentaerithrityl-tetranitrate results in unexpected, tolerance-devoid coronary- and venodilation. London, UK: Portland Press. Effects of continued pentaerythritol tetranitrate administration on myocardial circulation and metabolism.
Experientia β Organic nitrates in cardiovascular disease [Review]. Cell Mol Biol Noisy-le-grand β Bohm, C; Haustein, KO. Effect of pentaerithrityl tetranitrate on parameters of the microcirculation. Int J Clin Pharmacol Ther β Pentaerythrityltetranitrate PETN improves utero- and feto-placental Doppler parameters in pregnancies with impaired utero-placental perfusion in mid-gestation - a secondary analysis of the PETN-pilot trial.
J Perinat Med β No evidence of toxicity or carcinogenicity of pentaerythritol tetranitrate given in the diet to F rats and B6C3F1 mice for up to two years. J Appl Toxicol β The correlation of pain relief with blood nitrate levels in angina pectoris when treated with pentaerythritol tetranitrate.
